As compounding pharmacies continue to develop around additive combinations, pharmaceutical stakeholders must closely monitor the clinical and regulatory implications
Back Sheridan, C (14 April 2025) 'Not just obesity: GLP-1 receptor agonists advance on addiction', Nature Biotechnology , 43, 455-47.Back Sims, EK, Carr, ALJ, Oram, RA, et al (15 July 2022) '100 years of insulin: celebrating the past, present and future of diabetes therapy', Nature Medicine , 27/7, 1154-64
This is the solvent in which all the ingredients are dissolved
Liu CC, Hu J, Tsai CW, Yue M, Melrose HL, Kanekiyo T, et al
Copycat products and inadequate oversight: We already have a troubling market of compounded products, "research" peptides, microdosing plans, longevity packages, and cosmetic weight-loss programs with inadequate medical supervision
[3] The availability of an oral formulation offers an alternative for patients who prefer or require an oral medication over injections